Benchmarking CIN3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines

OBJECTIVE: In 2012, the United States Preventive Services Task Force (USPSTF) and a consensus of 25 organizations endorsed concurrent cytology and HPV testing (“cotesting”) for cervical cancer screening. Past screening and management guidelines were implicitly based on risks defined by Pap-alone, wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Katki, Hormuzd A., Schiffman, Mark, Castle, Philip E., Fetterman, Barbara, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Raine-Bennett, Tina R., Gage, Julia C., Kinney, Walter K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616419/
https://ncbi.nlm.nih.gov/pubmed/23519302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/LGT.0b013e318285423c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares